Distillate Capital Partners’s Universal Health Services UHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.5M Buy
77,035
+2,257
+3% +$367K 0.6% 100
2026
Q1
$13.4M Sell
74,778
-51
-0.1% -$10.5K 0.71% 84
2025
Q4
$16.3M Sell
74,829
-1,036
-1% -$229K 0.84% 52
2025
Q3
$15.5M Sell
75,865
-1,018
-1% -$183K 0.8% 56
2025
Q2
$13.9M Sell
76,883
-4,477
-6% -$808K 0.75% 75
2025
Q1
$15.3M Sell
81,360
-7,195
-8% -$1.31M 0.78% 59
2024
Q4
$15.9M Buy
+88,555
New +$18M 0.78% 66
2024
Q3
Sell
-73,985
Closed -$13.7M 109
2024
Q2
$13.7M Buy
+73,985
New +$13.1M 0.72% 85
2022
Q3
Sell
-40,915
Closed -$4.12M 125
2022
Q2
$4.12M Buy
+40,915
New +$5.12M 0.59% 97
2021
Q1
Sell
-12,616
Closed -$1.72M 131
2020
Q4
$1.72M Buy
+12,616
New +$1.57M 0.82% 53

Other funds holding UHS

Distillate Capital Partners's UHS Position: Q2 2026 in Review

Distillate Capital Partners increased its Universal Health Services (UHS) stake by 3% in Q2 2026, buying an estimated $367K and bringing the position to 77,035 shares worth $11.5M. The position accounts for 0.6% of the portfolio, ranked #100.

Distillate Capital Partners first reported a position in UHS in Q4 2020 and has held it in 10 quarters since. The position peaked at $16.3M in Q4 2025. 593 funds tracked by Wall St. Rank hold UHS as of Q2 2026.

  • Distillate Capital Partners held 77,035 shares of Universal Health Services worth $11.5M as of Q2 2026.
  • Distillate Capital Partners bought 2,257 Universal Health Services shares in Q2 2026, an estimated $367K.
  • Universal Health Services made up 0.6% of Distillate Capital Partners's portfolio in Q2 2026, its #100 holding.
  • Distillate Capital Partners first reported a position in Universal Health Services in Q4 2020 and has held it in 10 quarters since.
  • Distillate Capital Partners's Universal Health Services position peaked at $16.3M in Q4 2025.
  • 593 funds tracked by Wall St. Rank held Universal Health Services as of Q2 2026.

Based on Distillate Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.